Risk factors for primary sclerosing cholangitis-Reference-Cited by-同舟云学术

Risk factors for primary sclerosing cholangitis

Published:2015-08-28 Issue:1 Volume:36 Page:84-91
ISSN:1478-3223
Container-title:Liver International
language:en
Short-container-title:Liver Int

Author:

Boonstra Kirsten¹,de Vries Elisabeth M. G.¹,van Geloven Nan²,van Erpecum Karel J.³,Spanier Marcel⁴,Poen Alexander C.⁵,van Nieuwkerk Carin M.⁶,Witteman Ben J.⁷,Tuynman Hans A.⁸,Naber Anton H.⁹,Kingma Paul J.⁹,Beuers Ulrich¹,Ponsioen Cyriel Y.¹,

Affiliation:

1. Department of Gastroenterology and Hepatology; Academic Medical Center; Amsterdam the Netherlands

2. Clinical Research Unit; Academic Medical Center; Amsterdam the Netherlands

3. Department of Gastroenterology and Hepatology; University Medical Center Utrecht; Utrecht the Netherlands

4. Department of Gastroenterology and Hepatology; Rijnstate Hospital; Arnhem the Netherlands

5. Department of Gastroenterology and Hepatology; Isala Clinics; Zwolle the Netherlands

6. Department of Gastroenterology and Hepatology; VU Medical Center; Amsterdam the Netherlands

7. Department of Gastroenterology and Hepatology; Gelderse Vallei Hospital; Ede the Netherlands

8. Department of Gastroenterology and Hepatology; Medical Center Alkmaar; Alkmaar the Netherlands

9. Department of Gastroenterology and Hepatology; Tergooiziekenhuizen; Hilversum/Blaricum the Netherlands

Funder

Dr. Falk Benelux

AbbVie

Tramedico

Publisher

Wiley

Subject

Hepatology

Link

http://onlinelibrary.wiley.com/wol1/doi/10.1111/liv.12894/fullpdf

Reference37 articles.

1. Population-based epidemiology, malignancy risk, and outcome of primary sclerosing cholangitis;Boonstra;Hepatology,2013

2. Incidence and risk factors for cholangiocarcinoma in primary sclerosing cholangitis;Burak;Am J Gastroenterol,2004

3. High lifetime risk of cancer in primary sclerosing cholangitis;Claessen;J Hepatol,2009

4. Primary sclerosing cholangitis is associated with a distinct phenotype of inflammatory bowel disease;Boonstra;Inflamm Bowel Dis,2012

5. Meta-analysis identifies 29 additional ulcerative colitis risk loci, increasing the number of confirmed associations to 47;Anderson;Nat Genet,2011

Cited by 23 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. PheWAS and cross-disorder analysis reveal genetic architecture, pleiotropic loci and phenotypic correlations across 11 autoimmune disorders;Frontiers in Immunology;2023-09-21

2. AASLD practice guidance on primary sclerosing cholangitis and cholangiocarcinoma;Hepatology;2022-10-20

3. PheWAS and cross-disorder analyses reveal genetic architecture, pleiotropic loci and phenotypic correlations across 11 autoimmune disorders;2022-10-20

4. Gene Set Enrichment Analysis Detected Immune Cell-Related Pathways Associated with Primary Sclerosing Cholangitis;BioMed Research International;2022-08-26

5. Epidemiology and outcomes of primary sclerosing cholangitis: an Australian multicentre retrospective cohort study;Hepatology International;2022-06-03